Back
INmune Bio Vs. DocuSign Industry Stock Comparison
Sell
41
INMB
INmune Bio
Last Price:
$8.13
Seasonality Move:
36.2%
Buy
72
DOCU
DocuSign
Last Price:
$88.07
Seasonality Move:
13.69%
Sell
41
INmune Bio (INMB)
is a Sell
Is INmune Bio a Buy, Sell or Hold?
-
The current INmune Bio [INMB] share price is $8.12. The Score for INMB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
INMB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INMB Stock Price Chart
What is INmune Bio's stock price today?
-
The INmune Bio share price today is $8.12The current trend is relatively stagnant and INMB is experiencing buying pressure, which is a positive indicator for future bullish movement.
INMB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 50.29 | Buy |
Chaikin Money Flow: | 123366 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.71 - 8.91) | Sell |
Bollinger Bands (100): | (4.92 - 8.36) | Buy |
DOCU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 12.27 | Buy |
Relative Strength Index (14 RSI): | 57.09 | Buy |
Chaikin Money Flow: | 4428750 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (80.24 - 86.94) | Buy |
Bollinger Bands (100): | (77.8 - 94.24) | Buy |
INMB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.02 | Buy |
20-day SMA: | 8.07 | Buy |
50-day SMA: | 8.05 | Buy |
200-day SMA: | 6.88 | Buy |
8-day EMA: | 8.03 | Buy |
20-day EMA: | 8.13 | Sell |
50-day EMA: | 7.79 | Buy |
200-day EMA: | 7.38 | Buy |
DOCU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 83.48 | Buy |
20-day SMA: | 82.58 | Buy |
50-day SMA: | 87.95 | Buy |
200-day SMA: | 71.52 | Buy |
8-day EMA: | 34.28 | Buy |
20-day EMA: | 15.72 | Buy |
50-day EMA: | 6.66 | Buy |
200-day EMA: | 1.71 | Buy |
INmune Bio Earnings Growth & INMB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.29 per share.
DocuSign Earnings Growth & DOCU Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.01 per share, an increase this year of $0.66 per share, and a decrease next year of $0.03 per share.
INmune Bio Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
DocuSign Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |